Part 15/19:
Kenneth Raposa highlighted that approximately 80% of generic pharmaceuticals supplied in the US are produced overseas, predominantly in India. Additionally, China supplies a significant portion—many raw organic compounds and synthetic chemicals—necessary for manufacturing these medicines. This dependency raises concern over the resilience of US healthcare in crisis situations and the potential for supply disruptions during geopolitical conflicts or health emergencies.